review article | Q7318358 |
scholarly article | Q13442814 |
P50 | author | William David Foulkes | Q37829195 |
P2093 | author name string | Flanders TY | |
P2860 | cites work | Chronic pancreatitis and pancreatic cancer | Q23912525 |
Homozygous deletion map at 18q21.1 in pancreatic cancer | Q70908349 | ||
The hereditary pancreatitis gene maps to long arm of chromosome 7 | Q71625105 | ||
The significance of CD44 in human pancreatic cancer: I. High expression of CD44 in human pancreatic adenocarcinoma | Q71672224 | ||
The significance of CD44 in human pancreatic cancer: II. The role of CD44 in human pancreatic adenocarcinoma invasion | Q71672229 | ||
Frequency of homozygous deletion at p16/CDKN2 in primary human tumours | Q71721193 | ||
Familial pancreatic cancer | Q71726750 | ||
Allelotype of pancreatic adenocarcinoma using xenograft enrichment | Q71729160 | ||
Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia | Q72018776 | ||
Pancreatic cancer in industrial branches and occupations in Finland | Q72144250 | ||
The impact of family history on ovarian cancer risk. The Utah Population Database | Q72181741 | ||
Allelotype of pancreatic adenocarcinoma | Q72386220 | ||
Medical genetic study of eight pancreatic cancer-prone families | Q72587841 | ||
The Williams syndrome: evidence for possible autosomal dominant inheritance | Q72646763 | ||
Williams syndrome: autosomal dominant inheritance | Q72646769 | ||
A single ataxia telangiectasia gene with a product similar to PI-3 kinase | Q24323579 | ||
Epidemiology of and Risk Factors for Pancreatic Cancer | Q26345031 | ||
A genetic model for colorectal tumorigenesis | Q27860582 | ||
The DCC gene product in cellular differentiation and colorectal tumorigenesis | Q28238617 | ||
Expression and alternative splicing of the deleted in colorectal cancer (DCC) gene in normal and malignant tissues | Q28245715 | ||
Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers | Q28251857 | ||
A cell cycle regulator potentially involved in genesis of many tumor types | Q28251933 | ||
Identification of a chromosome 18q gene that is altered in colorectal cancers | Q28274172 | ||
Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma | Q28300339 | ||
Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes | Q28307762 | ||
A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells | Q28578219 | ||
ras oncogenes in human cancer: a review | Q29547769 | ||
DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1 | Q29616726 | ||
Neoplastic diseases in families of breast cancer patients | Q33674750 | ||
Familial pancreatic adenocarcinoma: association with diabetes and early molecular diagnosis | Q33676542 | ||
A large multisite cancer family is linked to BRCA2. | Q33683002 | ||
Germline p16 mutations in familial melanoma | Q34059915 | ||
Identification by representational difference analysis of a homozygous deletion in pancreatic carcinoma that lies within the BRCA2 region. | Q34169118 | ||
A cancer family syndrome in twenty-four kindreds | Q34177945 | ||
Increased risk of thyroid and pancreatic carcinoma in familial adenomatous polyposis | Q34378109 | ||
A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes | Q34385903 | ||
Progress report. Cancer of the pancreas | Q34473241 | ||
Cancer and the Peutz-Jeghers syndrome | Q34532616 | ||
Peutz-Jeghers syndrome: a clinicopathologic survey of the "Harrisburg family" with a 49-year follow-up | Q34686421 | ||
Increased risk of cancer in the Peutz-Jeghers syndrome | Q34690977 | ||
Diabetes mellitus as a risk factor for pancreatic cancer. A meta-analysis | Q34722287 | ||
K-ras and p53 gene mutations in pancreatic cancer: ductal and nonductal tumors progress through different genetic lesions. | Q34727489 | ||
Comparative genomic analysis of tumors: detection of DNA losses and amplification | Q34816301 | ||
Linkage analysis of chromosome 17q markers and breast-ovarian cancer in Icelandic families, and possible relationship to prostatic cancer. | Q35194149 | ||
K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization | Q35833155 | ||
Founding BRCA1 mutations in hereditary breast and ovarian cancer in southern Sweden | Q35881489 | ||
Mutations and altered expression of p16INK4 in human cancer. | Q35892778 | ||
Heredity and malignant melanoma: implications for early cancer detection | Q35900524 | ||
Systemic cancer and the FAMMM syndrome | Q35982685 | ||
Ocular pathology in the elfin face syndrome (the Fanconi-Schlesinger type of idiopathic hypercalcaemia of infancy). Histochemical and ultrastructural study of a case | Q67796772 | ||
Frequent loss of expression of the potential tumor suppressor gene DCC in ductal pancreatic adenocarcinoma | Q67845477 | ||
Participation in normal immune responses of a metastasis-inducing splice variant of CD44 | Q68007055 | ||
Cancer risk among patients with cystic fibrosis | Q68044184 | ||
Estimates of the worldwide frequency of sixteen major cancers in 1980 | Q68257962 | ||
Hereditary colorectal cancer | Q68309682 | ||
Cancer in homozygotes and heterozygotes of ataxia-telangiectasia and xeroderma pigmentosum in Britain | Q68322864 | ||
Life-style risk factors for pancreatic cancer in Louisiana: a case-control study | Q68444864 | ||
High frequency of Ki-ras codon 12 mutations in pancreatic adenocarcinomas | Q69506614 | ||
Adenocarcinoma of the Pancreas in Four Siblings | Q69554900 | ||
Pancreatic adenocarcinoma in an adolescent male with Peutz-Jeghers syndrome | Q69995974 | ||
A familial aggregation of pancreatic cancer. An in vitro study | Q70350550 | ||
Late mortality after surgery for peptic ulcer | Q70410897 | ||
Extracolonic cancer in hereditary nonpolyposis colorectal cancer | Q70557907 | ||
Ataxia-telangiectasia with dysgerminoma of right ovary, papillary carcinoma of thyroid, and adenocarcinoma of pancreas | Q70582740 | ||
Familial melanoma and pancreatic cancer. Ligurian Skin Tumor Study Group | Q70875347 | ||
Pancreatic carcinoma and hereditary nonpolyposis colorectal cancer: a family study | Q35992339 | ||
Cancer predisposition of ataxia-telangiectasia heterozygotes | Q37919232 | ||
Familial pancreatic cancer: clinicopathologic study of 18 nuclear families. | Q38042604 | ||
Cancer in survivors of childhood soft tissue sarcoma and their relatives | Q38518800 | ||
Morphoregulatory molecules | Q39517466 | ||
The ras gene family and human carcinogenesis | Q39638098 | ||
Familial pancreatic adenocarcinoma in three generations. A case report and a review of the literature | Q39805287 | ||
Hereditary pancreatitis: three new kindreds and a critical review of the literature | Q39922206 | ||
KRAS codon 12 mutations occur very frequently in pancreatic adenocarcinomas | Q40554859 | ||
Proportionate Mortality Study of Vietnam-Era Veterans of Michigan | Q40990087 | ||
The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds | Q41226231 | ||
Partial gastrectomy: a risk factor for carcinoma of the pancreas? | Q41369852 | ||
Breast and other cancers in families with ataxia-telangiectasia | Q41456075 | ||
Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families | Q42691997 | ||
Mutation analysis of the BRCA2 gene in 49 site-specific breast cancer families | Q43442419 | ||
Family studies of malignant melanoma and associated cancer | Q43848254 | ||
Hereditary pancreatitis. A kindred without gross aminoaciduria | Q43848326 | ||
Are malignant melanoma patients at higher risk for a second cancer? | Q44320367 | ||
Familial pancreatic cancer: a family study | Q44374966 | ||
Cancer of the pancreas in two brothers and one sister | Q44514994 | ||
Pancreas cancer and smoking, beverage consumption, and past medical history. | Q45156740 | ||
A prospective study of pancreatic cancer in the elderly | Q46131926 | ||
Pancreatic cancer and the familial atypical multiple mole melanoma (FAMMM) syndrome. | Q46412235 | ||
Variable gastrointestinal and urologic cancers in a Lynch syndrome II kindred | Q47638256 | ||
Pancreatitis is a risk factor for pancreatic cancer | Q48638030 | ||
Cholecystectomy not confirmed as a risk factor for pancreatic cancer | Q50174187 | ||
Estimates of the worldwide incidence of eighteen major cancers in 1985. | Q50609607 | ||
Food habits and pancreatic cancer: a case-control study of the Francophone community in Montreal, Canada. | Q51032716 | ||
Detection of ras gene mutations in pancreatic juice and peripheral blood of patients with pancreatic adenocarcinoma. | Q51141721 | ||
Mutations associated with familial melanoma impair p16INK4 function. | Q52537796 | ||
Cancer mortality patterns among women who served in the military: the Vietnam experience. | Q52879828 | ||
Reported family aggregation of pancreatic cancer within a population-based case-control study in the Francophone community in Montreal, Canada. | Q53398098 | ||
Tobacco, alcohol, and coffee and cancer of the pancreas. A population-based, case-control study in Quebec, Canada. | Q53399554 | ||
Frequent alterations of the tumor suppressor genes p53 and DCC in human pancreatic carcinoma. | Q53471748 | ||
Frequent somatic mutations of the APC gene in human pancreatic cancer | Q53485746 | ||
Life-time risk of different cancers in hereditary non-polyposis colorectal cancer (HNPCC) syndrome. | Q54598204 | ||
5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers | Q55480673 | ||
A Familial Syndrome of Pancreatic Cancer and Melanoma with a Mutation in theCDKN2Tumor-Suppressor Gene | Q55670980 | ||
Increased Risk of Pancreatic Cancer in Melanoma-Prone Kindreds withp16INK4Mutations | Q57250780 | ||
Familial carcinoma of the pancreas | Q57386670 | ||
Homozygotes for CDKN2 (p16) germline mutation in Dutch familial melanoma kindreds | Q57948954 | ||
Systematic Population-Based Assessment of Cancer Risk in First-Degree Relatives of Cancer Probands | Q59548851 | ||
Screening for hereditary non-polyposis colorectal cancer: A study of 22 kindreds in The Netherlands | Q62978425 | ||
P433 | issue | 11 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | adenocarcinoma | Q356033 |
pancreatic adenocarcinoma | Q18556189 | ||
P304 | page(s) | 889-898 | |
P577 | publication date | 1996-11-01 | |
P1433 | published in | Journal of Medical Genetics | Q14640281 |
P1476 | title | Pancreatic adenocarcinoma: epidemiology and genetics | |
P478 | volume | 33 |
Q35043915 | Bilateral burkitt lymphoma of the ovaries: a report of a case in a child with williams syndrome |
Q35093628 | Biotherapeutic approaches to pancreatic cancer |
Q38451695 | Cancer--a degenerative disorder? |
Q33741520 | Chronic pancreatitis and other risk factors for pancreatic cancer |
Q42173126 | Detection of oncogenes in chronic pancreatitis |
Q85995613 | Development of a cytokine-modified allogeneic whole cell pancreatic cancer vaccine |
Q33681640 | Genetic implications of double primary cancers of the colorectum and endometrium |
Q56264508 | Late onset cerebellar metastasis from oesophageal adenocarcinoma in Williams Syndrome |
Q34500864 | Novel INTeraction of MUC4 and galectin: potential pathobiological implications for metastasis in lethal pancreatic cancer. |
Q33942341 | Pancreatic cancer: a review of emerging therapies |
Q33806821 | Pancreatic cancer: any prospects for prevention? |
Q34027691 | Pancreatic cancer: can we screen? How should we stage? |
Q35003467 | Pancreatitis and pancreatic cancer in two large pooled case-control studies |
Q36641775 | Polymorphisms in GSTM1, GSTT1 and CYP1A1 and risk of pancreatic adenocarcinoma |
Q78748805 | Predictive value of clinical features at initial presentation in pancreatic adenocarcinoma: a series of 308 cases |
Q36646900 | Radiofrequency ablation combined with palliative surgery may prolong survival of patients with advanced cancer of the pancreas |
Q98177859 | Regional Variation of Pancreatic Cancer Incidence in the Nile Delta Region of Egypt over a Twelve-Year Period |
Q44861375 | Risk of pancreatic cancer among individuals with a family history of cancer of the pancreas |
Q25256788 | Serum cadmium levels in pancreatic cancer patients from the East Nile Delta region of Egypt |
Q73449668 | Strategy after diagnosis of pancreatic dysplasia |
Q34211033 | The role of genetic factors in the etiology of pancreatic adenocarcinoma: an update |
Q40877335 | Treatment of pancreatic cancer. Promises and problems of tamoxifen, somatostatin analogs, and gemcitabine |
Q39476544 | Unusually high rate of young-onset pancreatic cancer in the East Nile Delta region of Egypt |
Q34199896 | Update on familial pancreatic cancer |
Q52975244 | [Therapy of pancreatic adenocarcinoma]. |
Search more.